Andres Liivak Joins Kaye Scholer LLP's Pre-Eminent Life Sciences Transactions Practice
October 21, 2010
New York – Kaye Scholer announced today that Andres Liivak has joined the firm’s pre-eminent Life Sciences Transactions practice as a Partner in its New York office.
“Andres is an important addition to our firm as a whole, and to our Life Sciences Transactions practice in particular. He provides added strength to our firm’s highly regarded life sciences practice,” said Barry Willner and Michael B. Solow, Co-Managing Partners of Kaye Scholer.
Liivak will practice exclusively in the area of life sciences transactional matters, and brings his extensive dealmaking experience to the firm’s collaborative, multidisciplinary life sciences team, known for its licensing and collaborations, M&A and private equity, intellectual property litigation, product liability litigation, commercial and deal-related litigation, and bankruptcy and restructuring services.
Liivak has wide-ranging experience in bringing together partners and investors in the life sciences industry to build productive discovery, development, manufacturing and commercialization relationships through critical collaborations and strategic alliances, including joint ventures and innovative, leading-edge commercial structures. He has led numerous M&A deals and played key roles in spin-out and reorganization transactions involving the purchase, sale and transfer of complex life sciences assets, technologies and products, including out of bankruptcy. Liivak has been trusted by clients to help them grapple with strategic litigation problems and to put in place significant business arrangements settling deal-related commercial litigation and complex, bet-the-company intellectual property disputes.
“I am thrilled to be joining Kaye Scholer’s exceptional Life Sciences Transactions practice,” said Andres Liivak. “I look forward to working with my fellow partners throughout the United States, Asia and Europe in representing the world’s leading life sciences companies on their most important deals and other matters.”
“As licensing and collaborations, and M&A transactions in the life sciences arena continue to become more global, dynamic and complex, we are pleased to have some of the most respected and highly regarded lawyers serve our clients. Andres’ addition is just one more example of Kaye Scholer’s commitment and continuing strategy to grow our top-flight life sciences transactional practice,” said Adam H. Golden, Co-Chair of the firm’s Corporate & Finance Department and Chair of the firm’s Life Sciences Transactions practice.
About Kaye Scholer
Kaye Scholer's Life Sciences practice is routinely praised by clients and legal publications alike. Chambers USA: America’s Leading Lawyers for Business (2010) notes “Kaye Scholer's [life sciences] practice is praised for its deep industry knowledge and the resources of its network of offices,” and the firm’s Corporate practice is praised for “achieving superb results.” Chambers further notes that clients make a point of utilizing Kaye Scholer “when transactions are especially complicated or have international elements,” and that clients praise Kaye Scholer lawyers as “expert in M&A and securities transactions,” “the type you want on your side when you are doing deals,” and “able to balance legal nuance with getting to the bottom line of what we want from a business perspective.”
Kaye Scholer refers to the international law firm Kaye Scholer LLP and its affiliates, with offices in Chicago, Frankfurt, London, Los Angeles, New York, Palo Alto, Shanghai, Washington, DC and West Palm Beach. Founded in New York City in 1917, Kaye Scholer represents public and private companies, governmental entities, financial institutions, and other organizations in matters around the world.